Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Predict S.P.A. Class B ( (IT:PRE) ) has provided an update.
Predict S.p.A. has continued to execute its share buyback program, purchasing 3,000 treasury shares between 26 and 30 January 2026 at a weighted average price of €0.8225 per share, for a total outlay of €2,467.50, bringing its total treasury holdings to 28,500 shares, or 0.367% of its share capital. The transactions, carried out via Integrae SIM S.p.A. under the authorization granted by shareholders, underscore Predict’s active capital management while it pursues growth in innovative healthcare technologies, potentially signaling confidence in the company’s valuation and offering a modest support to liquidity and share structure for current and prospective investors.
The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.45 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.
More about Predict S.P.A. Class B
Predict S.p.A., founded in 2008 in Bari, is an innovative Italian med-tech SME focused on in vivo diagnostics through the distribution of ultrasound and radiology equipment and the development of advanced technologies in breath analysis and digital healthcare. Organized into four strategic business units, the company supports diagnostic imaging, offers Mistral-branded breath analysis solutions for non-invasive screening and personalized medicine, and develops augmented reality and robotics platforms such as Aphel and Optip for clinical support, remote consultation, and educational applications, operating in partnership with major Italian university hospitals and research institutes and with offices in Bari and Milan.
Average Trading Volume: 27,391
Technical Sentiment Signal: Strong Buy
Current Market Cap: €6.33M
For detailed information about PRE stock, go to TipRanks’ Stock Analysis page.

